|
Prevention of Type 2 Diabetes Mellitus in Children Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Prevention of Type 2 Diabetes Mellitus in Children conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Prevention of Type 2 Diabetes Mellitus in Children Clinical research trials and Prevention of Type 2 Diabetes Mellitus in Children medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Prevention of Type 2 Diabetes Mellitus in Children. Prevention of Type 2 Diabetes Mellitus in Children Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Prevention of Type 2 Diabetes Mellitus in Children clinical trial. Test subjects typically obtain the finest healthcare available for their Prevention of Type 2 Diabetes Mellitus in Children condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Prevention of Type 2 Diabetes Mellitus in Children Prevention of Type 2 Diabetes Mellitus in Children
Prevention of Type 2 Diabetes Mellitus in Children
For Condition: Diabetes Mellitus, Type 2
Status: Recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: This is a pilot study to examine the short-term effects of supervised exercise on metabolic risk factors for type 2 diabetes mellitus in children from a population that is at high risk for this disease. We hypothesize that exercise will significantly improve insulin sensitivity in all children, especially in children who are already insulin resistant, thereby lowering the risk that they will go on to develop type 2 diabetes mellitus. The specific hypotheses being tested are: 1. Insulin resistance will be most evident in overweight children while an impaired ability of the pancreas to release insulin will be most evident in children with a family history of type 2 diabetes mellitus. 2. Exercise will significantly improve insulin resistance (as measured by the fasting glucose/insulin ratio) with little or no effect on insulin secretory capacity (as measured by circulating insulin concentration at 1, 3, and 5 minutes following an intravenous glucose load) in children. 3. Participation in a school-based health, nutrition, and exercise education program will have long-term beneficial effects on health-related behaviors and on insulin resistance.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Single Blind, Uncontrolled, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: 12 Years/15 Years
Genders: Both
Protocol Entry Criteria: Early adolescent
Total Enrollment: 300
Location and Contact Information:
Russ Berrie Pavilion *Recruiting*
New York City, New York, 10032
United States
Recruiting Michael Rosenbaum
New York Presbyterian Hospital *Recruiting*
New York City, New York,
United States
Recruiting Michael Rosenbaum 212-769-3070
Additional Information:
Study ID Numbers: 14239;
Study Start Date: December 2002
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073268
Other Diabetes Mellitus, Type 2 Studies:
1. Exenatide Compared with Twice-Daily Biphasic Insulin Aspart in Patients with Type 2 Diabetes Using Sulfonylurea and Metformin
2. Evaluation of the Effect of Pramlintide on Satiety and Food Intake
3. Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
4. Computer-assisted diabetes self-management interventions
5. Evaluation of the Bioavailability of Pramlintide
Related Studies:
Other Diabetes Mellitus, Type 2 Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
Prevention of Type 2 Diabetes Mellitus in Children
|
|
|
|
|
|
|
|